• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Introduction to 1-(2-Chlorophenyl)-1H-pyrazole-4-carbaldehyde (CAS No. 400877-15-8)

1-(2-Chlorophenyl)-1H-pyrazole-4-carbaldehyde, identified by the Chemical Abstracts Service Number (CAS No.) 400877-15-8, is a significant compound in the realm of pharmaceutical and chemical research. This heterocyclic aldehyde features a pyrazole core substituted with a 2-chlorophenyl group and a formyl (aldehyde) functionality at the 4-position. Its unique structural attributes make it a valuable intermediate in the synthesis of various biologically active molecules, particularly in the development of novel therapeutic agents.

The compound's molecular structure, characterized by a conjugated system involving the pyrazole ring, chlorobenzene moiety, and aldehyde group, contributes to its reactivity and potential applications. The presence of the aldehyde functionality allows for further derivatization through condensation reactions, Schiff base formations, or oxidation processes, enabling the creation of more complex scaffolds. Meanwhile, the electron-withdrawing nature of the 2-chlorophenyl group influences its electronic properties and interactions with biological targets.

In recent years, there has been growing interest in pyrazole derivatives due to their demonstrated pharmacological properties. Studies have highlighted their role in modulating enzyme activities, inhibiting inflammatory pathways, and exhibiting antimicrobial effects. The aldehyde derivative 1-(2-Chlorophenyl)-1H-pyrazole-4-carbaldehyde is no exception, showing promise as a precursor for drugs targeting neurological disorders, cardiovascular diseases, and infectious diseases.

One of the most compelling aspects of this compound is its utility in medicinal chemistry. Researchers have leveraged its scaffold to design molecules with enhanced binding affinity and selectivity. For instance, modifications at the pyrazole ring or the aromatic ring can fine-tune pharmacokinetic profiles, metabolic stability, and target interactions. The 2-chlorophenyl substituent plays a crucial role in these modifications by influencing electronic distribution and steric hindrance.

Recent advancements in computational chemistry have further accelerated the exploration of 1-(2-Chlorophenyl)-1H-pyrazole-4-carbaldehyde's potential. Molecular docking studies have identified its binding interactions with enzymes such as kinases and cyclases, which are pivotal in cancer signaling pathways. These virtual screenings have guided experimental designs, reducing trial-and-error approaches and optimizing lead compounds more efficiently.

The synthesis of 1-(2-Chlorophenyl)-1H-pyrazole-4-carbaldehyde involves multi-step organic transformations that highlight modern synthetic methodologies. Key steps often include chlorination of an aromatic precursor followed by cyclocondensation to form the pyrazole core. Subsequent functionalization at the 4-position introduces the aldehyde group through oxidation or formylation reactions. These synthetic routes underscore the compound's accessibility while maintaining high purity standards essential for pharmaceutical applications.

Beyond its synthetic significance, 1-(2-Chlorophenyl)-1H-pyrazole-4-carbaldehyde has been explored in drug discovery programs targeting specific diseases. For example, derivatives of this compound have shown inhibitory effects on Janus kinases (JAKs), which are overexpressed in autoimmune conditions like rheumatoid arthritis. By modulating JAK signaling pathways, these molecules offer potential therapeutic benefits with reduced side effects compared to traditional immunosuppressants.

The role of heterocyclic compounds like pyrazoles in medicinal chemistry cannot be overstated. Their structural versatility allows for diverse functionalization patterns, making them ideal candidates for generating novel drug candidates. The aldehyde group in 1-(2-Chlorophenyl)-1H-pyrazole-4-carbaldehyde serves as a versatile handle for further chemical modifications, enabling researchers to explore a wide spectrum of biological activities.

In conclusion,1-(2-Chlorophenyl)-1H-pyrazole-4-carbaldehyde (CAS No. 400877-15-8) represents a cornerstone in modern pharmaceutical research. Its unique structural features and reactivity make it indispensable for synthesizing biologically active molecules with therapeutic potential. As research continues to uncover new applications for this compound and its derivatives, its importance in drug discovery is set to grow even further.

• 1053085-34-9(1-(3-Chlorophenyl)-1H-pyrazole-4-carboxylic acid)
• 925155-57-3(1-1-(2-Chlorophenyl)-1H-pyrazol-4-ylethanone)
• 138907-80-9(1-(4-chlorophenyl)-1H-pyrazole-4-carboxylic acid)
• 925580-76-3(1-1-(4-Chlorophenyl)-1H-pyrazol-4-ylethanone)
• 1186663-52-4(3-Chloro-4-(1H-pyrazol-1-YL)benzaldehyde)
• 925142-81-0(1-1-(3-Chlorophenyl)-1H-pyrazol-4-ylethanone)
• 445302-83-0(1-(3,4-Dichlorophenyl)-1H-pyrazole-4-carbaldehyde)
• 400877-18-1((1-(2-Chlorophenyl)-1H-pyrazol-4-yl)methanamine)
• 400877-26-1(1-(3-Chlorophenyl)-1H-pyrazole-4-carbaldehyde)
• 63874-99-7(1-(4-Chlorophenyl)-1H-pyrazole-4-carbaldehyde)